¹Department of Chemistry and Biochemistry, College of Medicine, Al-Nahrain University, Baghdad, Iraq
²Department of Medicine, College of Medicine, Al-Nahrain University, Baghdad, Iraq
³The Dialysis unit, Al_Imamain Al_Khadhimain Medical City Hospital, Baghdad, Iraq DOI : 10.29228/jrp.2024.00 Pulmonary hypertension (PHT) is a serious condition characterized by increased blood pressure in the pulmonary arteries, leading to reduced blood flow and increased strain on the heart. Secondary PHT refers to cases where is Pulmonary hypertension a consequence of an underlying condition, and one such condition is ESRD. This work aimed to study the role of Alpha-1-acid Glycoprotein (AGP) & Pro-B-Natriuretic Peptide (BNP) in the Ddevelopment of PHT in patients under Hemodialysis. A cross-sectional observational study was conducted on 120 patients who visited the Al-Imamain Al-Khadhimain Medical City Hospital, Baghdad, Iraq, between May 2023 and July 2023 and were diagnosed with end-stage renal disease (ESRD) and underwent regular hemodialysis. Levels of AGP and BNP were measured, and clinical characteristics, including gender, age, hemodialysis duration, frequency of hemodialysis sessions per week, body mass index (BMI), and biochemical parameters such as parathyroid hormone (PTH), Ca, PO4, and albumin, were analyzed.Ca levels were significantly higher in the PHT group (8.12 ± 1.09 mg/dL) compared to the NPHT group (7.50 ± 1.10 mg/dL). AGP and BNP levels were significantly elevated in PHT patients (86.50 ± 16.54 ng/ml and 314.79±80.82 pg/ml; respectively) in comparison with NPHT group (41.98 ± 10.89 ng/ml and 211.87 ± 46.24 pg/ml; respectively). the results of the logistic regression analysis indicate that AGP has a significant positive effect on the odds of observing PHT, suggesting that higher AGP levels are associated with an increased likelihood of PHT.Patients with pulmonary hypertension who were receiving hemodialysis also had considerably higher levels of alpha-1-acid glycoprotein and pro-B-natriuretic peptide. These biomarkers might be useful resources for detecting and keeping track of pulmonary hypertension in this patient population. Keywords : AGP; ESRD; Hemodialysis; Pro-B-Natriuretic Peptide; Pulmonary hypertension